Metabolic abnormalities in cachexia and anorexia

Nutrition

Volumn 16, Issue 10, 2000, Pages 1013-1014

  Tisdale, Michael J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cori cycle; Eicosapentaenoic acid; Lipid mobilizing factor; Proteolysis inducing factor

Indexed keywords

GLYCOPROTEIN; ICOSAPENTAENOIC ACID;

ANOREXIA; BODY MASS; CACHEXIA; CANCER; CANCER PATIENT; CARBOHYDRATE METABOLISM; CATABOLISM; CONFERENCE PAPER; ENERGY EXPENDITURE; GLUCONEOGENESIS; HUMAN; LIPOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; URINALYSIS;

ANOREXIA; CACHEXIA; CARBOHYDRATES; EICOSANOIC ACIDS; HUMAN; LIPIDS; PROTEINS;

EID: 0033772576     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00409-3     Document Type: Conference Paper

References (34)

1. Weight loss and nutritional abnormalities in cancer patients; incidence, severity and significance
2. Uncomplicated starvation versus cancer cachexia
3. Substrate balances across colonic carcinomas in humans
4. Altered glucose metabolism in metastatic carcinoma
5. Gluconeogenesis from alanine in patients with progressive malignant disease
6. Glucose turnover, gluconeogenesis from glycerol and estimation of net glucose cycling in cancer patients
7. Effect of different tumor types on resting energy expenditure
8. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer
9. A review of cancer cachexin and abnormal glucose metabolism in humans with cancer
10. Cardiovascular and metabolic response to adrenaline-infusion in weight-losing patients with and without cancer
11. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
12. Anorexia and weight loss in cancer patients
13. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host
14. Effect of Krebs-2 carcinoma on the lipide metabolism of male Swiss mice
15. Studies on the mechanism of carcass fat depletion in experimental cancer
16. A lipid mobilizing factor in serum of tumor-bearing mice
17. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients
18. Alterations in serum lipolytic activity of cancer patients with response to therapy
19. Identification of a human tumor-derived lipolysis-promoting factor
20. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumor growth in vivo by eicosapentaenoic acid
21. Elevated levels of circulatory cachectin/tumor necrosis factor in patients with the acquired immunodeficiency syndrome
22. Increased expression of the mRNA for the hormone-sensitive lipase in adipose tissue of cancer patients
23. Protein-calorie undernutrition in hospitalized cancer patients
24. Skeletal muscle metabolism in patients with malignant tumor
25. Protein synthesis in muscle measured in vivo in cachectic patients with cancer
26. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats
27. Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss
28. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia
29. Characterization of a cancer cachectic factor
30. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation
31. Induction of muscle protein degradation and weight loss by a tumor product
32. Induction of muscle protein degradation by a tumour factor
33. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover
34. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer